Live Breaking News & Updates on Fournier Majoie Foundation For Innovation

Stay updated with breaking news from Fournier majoie foundation for innovation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PEP-Therapy and Institut Curie announce first patients dosed in Phase I clinical trial of PEP-010 for the treatment of advanced solid tumors

/PRNewswire/ PEP-Therapy, a clinical-stage biotechnology company developing cell penetrating peptides as targeted therapies in oncology, and Institut Curie,. ....

Czech Republic , France General , Marie Curie , Bernard Majoie , Sylvie Berrebi , Laboratoires Fournier , Christophe Le Tourneau , Gustave Roussy , Antoine Prestat , Institut Curie , Seed Fund , Head Of The Department Drug Development , Sorbonne University , Fournier Majoie Foundation For Innovation , Baclesse Center , Cell Penetrating , Interfering Peptides , Professor Christophe Le Tourneau , Medical Oncologist , Drug Development , Principal Investigator , Triple Negative Breast Cancer , Ovarian Cancer , Maximum Tolerated Dose , Italian Angels , Magna Capital Partners ,

PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical development of its lead candidate PEP-010

as well as a €1 million loan from Bpifrance
PARIS, July 19, 2021 /PRNewswire/
PEP-Therapy, a biotechnology company developing cell penetrating peptides as targeted therapies for the treatment of cancers, announced today that it raised an additional €2.6 million ($3 million) in an extension of its Series A financing round, bringing the total raised in this round to €5.4 million ($6.4 million). This new funding comprises €1.6 million in equity from Anaxago, i&i Prague and BADGE as well as a €1 million loan from Bpifrance.
This increased financial support highlights the potential of PEP-010, as well as PEP-Therapy s Cell Penetrating & Interfering Peptide (CP&IP) technology platform, which was first developed at Sorbonne University and Institut Curie. ....

Czech Republic , France General , Laboratoires Fournier , Bernard Majoie , Antoine Prestat , Gustave Roussy , Sylvie Berrebi , Institut Curie , Gaston Vasseur , Seed Fund , Sorbonne University , Fournier Majoie Foundation For Innovation , Bpifrance This , Cell Penetrating , Interfering Peptide , Investment Manager , Fonds Unique Interminist , Interfering Peptides , Italian Angels , Magna Capital Partners , Business Angels Des Grandes Ecoles , Seventure Partners , Founding Chairman , Fournier Majoie Foundation , Anaxago Venture Capital , Venture Capital ,

PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical development of its lead candidate PEP-010

PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical development of its lead candidate PEP-010
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Czech Republic , France General , Laboratoires Fournier , Bernard Majoie , Antoine Prestat , Gustave Roussy , Sylvie Berrebi , Institut Curie , Gaston Vasseur , Seed Fund , Sorbonne University , Fournier Majoie Foundation For Innovation , Bpifrance This , Cell Penetrating , Interfering Peptide , Investment Manager , Fonds Unique Interminist , Interfering Peptides , Italian Angels , Magna Capital Partners , Business Angels Des Grandes Ecoles , Seventure Partners , Founding Chairman , Fournier Majoie Foundation , Anaxago Venture Capital , Venture Capital ,

PEP-Therapy raises €2.75 million in Series A financing to advance its lead candidate, PEP-010, into the clinic

PEP-Therapy raises €2.75 million in Series A financing to advance its lead candidate, PEP-010, into the clinic
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , France General , Michele Marzola , Bernard Majoie , Urogen Pharma , Sylvie Berrebi , Philippe Tramoy , Laboratoires Fournier , Antoine Prestat , Gustave Roussy , Nathaniel Dahan , Institut Curie , Citigate Dewe Rogerson , Seed Fund , French National Agency For Medicines , Milan Stock Exchange , Fournier Majoie Foundation For Innovation , Health Products , Magna Capital Partners Ltd , Sorbonne University , Life Sciences Lead Investor , Italian Angels , Magna Capital Partner , Business Angels Des Grandes Ecoles , Seventure Partners , Unique Interminist ,

PEP-Therapy raises €2.75 million in Series A financing to advance its lead candidate, PEP-010, into the clinic

PEP-Therapy raises €2.75 million in Series A financing to advance its lead candidate, PEP-010, into the clinic
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United States , France General , Michele Marzola , Bernard Majoie , Urogen Pharma , Sylvie Berrebi , Philippe Tramoy , Laboratoires Fournier , Antoine Prestat , Gustave Roussy , Nathaniel Dahan , Institut Curie , Citigate Dewe Rogerson , Seed Fund , French National Agency For Medicines , Milan Stock Exchange , Fournier Majoie Foundation For Innovation , Health Products , Magna Capital Partners Ltd , Sorbonne University , Life Sciences Lead Investor , Italian Angels , Magna Capital Partner , Business Angels Des Grandes Ecoles , Seventure Partners , Unique Interminist ,